This Canadian startup plans to repurpose Cannabis-derived drug for cardiac diseases linked to COVID-19

Akseera Pharma plans to use CBD as a potential therapy for cardiac arrhythmias, or irregular heartbeat, with possible link to COVID-19. Launches subsidiary in India for the manufacture, distribution and export of the drug.